Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-10-31FDA Approved: MESALAMINE — Original Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva Pharmaceuticals USA, Inc.'s original application for Mesalamine, a 5-aminosalicylic acid drug used in inflammatory bow…
-
CLINICAL_TRIALS trial_result · 2008-09-08Clinical Trial Update: Study for the Treatment of Ulcerative Colitis With Adacolumn [Phase 3]
Phase 3 study evaluating Adacolumn for Ulcerative Colitis has completed.
-
CLINICAL_TRIALS research · 2008-09-03Clinical Trial Update: The Effect of Infliximab on Sperm Quality
A clinical trial is examining the effect of infliximab on sperm quality in people with Crohn's disease or ulcerative colitis. The current st…
-
CLINICAL_TRIALS research · 2008-08-05Clinical Trial Update: An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis
An observational follow-up study is described for subjects receiving salvage therapy after prior treatment in a visilizumab study for intrav…
-
CLINICAL_TRIALS trial_result · 2008-07-30Clinical Trial Update: FishGastro Study: Fish Consumption and Gastro-Intestinal Health [NA]
The FishGastro Study, sponsored by Quadram Institute Bioscience, has completed and investigates the relationship between fish consumption an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-06-05Clinical Trial Update: Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating retarded phosphatidylcholine in steroid-dependent chronic active ulcerative colitis has completed. The sponsor list…
-
FDA approval · 2008-05-23FDA Approved: CANASA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for CANASA (mesalamine) from Allergan, Inc., marking an additional approval for this product.
-
CLINICAL_TRIALS trial_result · 2008-04-25Clinical Trial Update: Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis [Phase 3]
Phase 3 trial of COLAL-PRED for moderate acute ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-15Clinical Trial Update: Asacol Dosing Study for Active Ulcerative Colitis [Phase 4]
Phase 4 dosing study of Asacol (mesalamine) for active ulcerative colitis has completed, according to the trial update.
-
FDA approval · 2007-12-28FDA Approved: BALSALAZIDE DISODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved an original application for balsalazide disodium, a generic oral anti-inflammatory for ulcerative colitis, for Hikma Pharmaceut…
-
FDA approval · 2007-12-28FDA Approved: BALSALAZIDE DISODIUM — Original Application (Apotex Corp.)
The FDA approved Apotex Corp.'s generic balsalazide disodium (ANDA) as a generic version of balsalazide for the treatment of ulcerative coli…
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease [NA]
The study evaluating nasal calcitonin for bone mineral loss in children and adolescents with inflammatory bowel disease has completed. The c…
-
CLINICAL_TRIALS trial_result · 2007-09-27Clinical Trial Update: Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205) [Phase 4]
Phase 4 clinical trial update reporting the completion of a study evaluating Adacolumn for ulcerative colitis (companion to US Study 512-04-…
-
CLINICAL_TRIALS research · 2007-09-24Clinical Trial Update: NBI With Magnification for Dysplasia Detection in Ulcerative Colitis [NA]
This clinical trial entry reports on a study evaluating narrow-band imaging with magnification for dysplasia detection in ulcerative colitis…
-
FDA approval · 2007-07-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
FDA approval · 2007-07-10FDA Approved: DIPENTUM — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for DIPENTUM (olsalazine sodium) submitted by Viatris Specialty LLC.
-
FDA approval · 2007-06-26FDA Approved: PENTASA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Pentasa (mesalamine) from Takeda Pharmaceuticals America, resulting in an approved additiona…
-
CLINICAL_TRIALS trial_result · 2007-06-22Clinical Trial Update: Assessment of Pulmonary Involvement inUlcerative Colitis by Induced Sputum [NA]
This clinical trial update notes that a study assessing pulmonary involvement in Ulcerative Colitis using induced sputum has completed, with…
-
CLINICAL_TRIALS trial_result · 2007-06-21Clinical Trial Update: CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission [Phase 3]
A completed Phase 3 trial (CORE) evaluating OPC-6535 in combination with Asacol for maintaining remission in ulcerative colitis.
-
FDA approval · 2007-06-12FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for infliximab (Remicade) submitted by Janssen Biotech, Inc. The approval updates the labeling to re…
-
FDA approval · 2007-05-22FDA Approved: MESALAMINE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for MESALAMINE from Padagis Israel Pharmaceuticals Ltd under an ANDA. The approval signifies a suppl…
-
FDA approval · 2007-04-19FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for infliximab (Remicade) from Janssen Biotech, Inc., updating the product labeling per the supp…
-
FDA approval · 2007-03-16FDA Approved: MESALAMINE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved a supplemental application for mesalamine from Padagis Israel Pharmaceuticals Ltd. This action updates regulatory approval …
-
CLINICAL_TRIALS trial_result · 2007-02-12Clinical Trial Update: Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis [Phase 2]
A Phase 2 dose-finding trial evaluating slow-release phosphatidylcholine for pancolitis has completed.
-
FDA approval · 2007-01-16FDA Approved: LIALDA — Original Application (Takeda Pharmaceuticals America, Inc.)
FDA approval of LIALDA (mesalamine) under Takeda Pharmaceuticals America's original NDA for the treatment of ulcerative colitis.